Search

Fereydoun G Sajjadi

from Fairfax, VA
Age ~65

Fereydoun Sajjadi Phones & Addresses

  • 10143 Red Spruce Rd, Fairfax, VA 22032 (703) 323-0042
  • San Diego, CA
  • 10205 Merridith Cir, Burke, VA 22015 (703) 250-1019
  • 1548 Plumtree Dr, Encinitas, CA 92024 (760) 632-8759
  • Arkansas City, KS
  • Pasadena, CA
  • 1548 Plumtree Dr, Encinitas, CA 92024 (760) 898-1668

Work

Company: Uspto Jun 2005 Position: Supervisory patent examiner and acting director tc1600

Education

Degree: Doctorates, Doctor of Philosophy School / High School: The University of British Columbia 1982 to 1986 Specialities: Genetics

Emails

Industries

Government Administration

Resumes

Resumes

Fereydoun Sajjadi Photo 1

Project Leader

View page
Location:
Fairfax, VA
Industry:
Government Administration
Work:
Uspto
Supervisory Patent Examiner and Acting Director Tc1600

Gensia
Project Leader
Education:
The University of British Columbia 1982 - 1986
Doctorates, Doctor of Philosophy, Genetics

Publications

Us Patents

Method For Analyzing Quantitative Expression Of Genes

View page
US Patent:
59687843, Oct 19, 1999
Filed:
Jan 15, 1997
Appl. No.:
8/784208
Inventors:
Dominic G. Spinella - La Costa CA
Fereydoun G. Sajjadi - Encinitas CA
Assignee:
Chugai Pharmaceutical Co., Ltd. - Tokyo
International Classification:
C12P 1934
C12N 1564
US Classification:
435 911
Abstract:
The present invention provides novel methods for identifying gene expression patterns in mRNA populations. The methods are useful for determining differential gene expression among various cells or tissues, including cells or tissues of a target organism. The invention also provides methods of determining the frequency of gene expression in mRNA populations, thus providing a method of comparing gene expression frequency among various cells or tissues. The present invention also provides methods for isolating genes corresponding to tag sequences identified according to the methods of the present invention. Furthermore, sequences that are identified according to the present invention may be used to diagnose the presence of disease.

Eph-Related Tyrosine Kinases, Nucleotide Sequences And Methods Of Use

View page
US Patent:
54570484, Oct 10, 1995
Filed:
Dec 3, 1993
Appl. No.:
8/162809
Inventors:
Elena B. Pasquale - San Diego CA
Fereydoun G. Sajjadi - San Diego CA
Assignee:
La Jolla Cancer Research Foundation - La Jolla CA
International Classification:
C12N 912
C12N 1554
US Classification:
4352523
Abstract:
The invention is directed to substantially purified Eph-related protein tyrosine kinases, or functional fragments thereof, having about 23 to 66 percent amino acid sequence identity in their carboxyl terminal variable regions compared to known members of the Eph subclass of tyrosine kinases. Nucleic acids encoding such Eph-related protein tyrosine kinases, vectors and host cells are also provided. The invention is also directed to a method of diagnosing cancer and determining cancer prognosis. The method includes removing a tissue or cell sample from a subject suspected of having cancer and determining the level of Eph-related protein tyrosine kinase in the sample, wherein a change in the level or activity of a Eph-related protein tyrosine kinase compared to a normal sample indicates the presence of a cancer or indicates the level of malignancy of a cancer.
Fereydoun G Sajjadi from Fairfax, VA, age ~65 Get Report